Arrowhead Pharmaceuticals, Inc. Liquidation Value
ARWR
Other
Cash & Equivalents
$371.92M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $371.92M
Total Obligations: -$457.08M
$-85.17M
Per share: $-0.62
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $371.92M
AR: $218.87M
Total Obligations: -$457.08M
$133.70M
Per share: $0.97
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $371.92M
AR: $218.87M
Inventory: $0
Total Obligations: -$457.08M
$133.70M
Per share: $0.97
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-85.17M | $-0.62 |
| Liquid Liquidation Value | $133.70M | $0.97 |
| Operating Liquidation Value | $133.70M | $0.97 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $371.92M |
| Accounts Receivable | $218.87M |
| Inventory | N/A |
| Current Liabilities | $347.43M |
| Long-term Debt | N/A |
| Op. Lease Liability | $109.66M |
| Finance Lease | N/A |
| Shares Outstanding | 137.4M |
Explore all 149 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $371.92M | $218.87M | N/A | $32.94M | $347.43M | N/A | $109.66M | N/A |
| 2025-09-30 | $446.45M | $6.82M | N/A | $17.67M | $195.49M | N/A | $111.40M | N/A |
| 2025-06-30 | $131.99M | $9.70M | N/A | $33.05M | $194.53M | N/A | $112.70M | N/A |
| 2025-03-31 | $187.81M | $2.37M | N/A | $9.98M | $220.54M | N/A | $114.31M | N/A |
▼ Community Notes